investorscraft@gmail.com

Intrinsic ValueCEDAR.Co.,Ltd. (2435.T)

Previous Close¥220.00
Intrinsic Value
Upside potential
Previous Close
¥220.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

CEDAR.Co.,Ltd. operates in Japan's growing elderly care sector, providing a comprehensive suite of nursing and rehabilitation services. The company's revenue model is built on fee-for-service arrangements, covering day care, resident life care, home-visit nursing, and short-term residency care. As Japan's aging population expands, demand for such services is rising, positioning CEDAR as a key player in a structurally supportive market. The company differentiates itself through localized service networks and integrated care solutions, catering to both private-pay and government-subsidized clients. Its focus on home-based and community care aligns with Japan's policy shift away from institutionalization, enhancing its long-term relevance. However, the sector remains fragmented, with regional competition and regulatory oversight influencing profitability. CEDAR's mid-sized scale allows agility in adapting to demographic shifts while maintaining operational control over service quality—a critical factor in reputation-sensitive healthcare markets.

Revenue Profitability And Efficiency

For FY2024, CEDAR reported revenue of JPY 17.3 billion, with net income of JPY 203 million, reflecting tight margins in the capital-intensive care sector. Operating cash flow stood at JPY 1.47 billion, partially offset by JPY 479 million in capital expenditures. The modest net income suggests cost pressures from labor and facility maintenance, common in Japan's care industry where staffing costs account for ~60-70% of expenses.

Earnings Power And Capital Efficiency

Diluted EPS of JPY 18.09 indicates limited but stable earnings capacity, typical for regulated care providers. The company's capital efficiency is constrained by high fixed costs for facilities and equipment, though its cash flow generation supports ongoing operations. Debt servicing costs likely weigh on net margins given JPY 15.2 billion in total debt.

Balance Sheet And Financial Health

With JPY 1.64 billion in cash against JPY 15.2 billion debt, leverage appears elevated, though common for care operators financing real estate and equipment. The debt load may reflect expansion needs in a sector requiring upfront infrastructure investments. Liquidity seems adequate with positive operating cash flow covering interest obligations.

Growth Trends And Dividend Policy

Growth is tied to Japan's aging demographics, with organic expansion possible through new care centers. A JPY 6/share dividend implies a ~33% payout ratio, balancing shareholder returns with reinvestment needs. Future growth may require selective acquisitions or government partnership models to mitigate capex burdens.

Valuation And Market Expectations

At a JPY 2.44 billion market cap, the stock trades at ~12x net income, reflecting sector risks like labor shortages and reimbursement pressures. The negative beta suggests defensive characteristics, though limited earnings scalability may cap valuation upside.

Strategic Advantages And Outlook

CEDAR's regional expertise and diversified service portfolio provide resilience, but success hinges on navigating staffing challenges and reimbursement policies. Strategic priorities likely include operational digitization and partnerships to improve margins. Long-term prospects remain favorable given demographic trends, but execution risks persist.

Sources

Company filings, Japan healthcare sector reports

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount